Related references
Note: Only part of the references are listed.Ribavirin Potentiates Interferon Action by Augmenting Interferon-Stimulated Gene Induction in Hepatitis C Virus Cell Culture Models
Emmanuel Thomas et al.
HEPATOLOGY (2011)
The recent breakthroughs in the understanding of host genomics in hepatitis C
Andri Rauch et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response
Ruth Broering et al.
GUT (2010)
Interferon-lambda Genotype and Low Serum Low-Density Lipoprotein Cholesterol Levels in Patients with Chronic Hepatitis C Infection
Josephine H. Li et al.
HEPATOLOGY (2010)
ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment
Limin Chen et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication
Daniel M. Jones et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b A Randomized Trial
Donald M. Jensen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Barbara Rehermann
JOURNAL OF CLINICAL INVESTIGATION (2009)
Modulation of alpha interferon anti-hepatitis C virus activity by ISG15
Pong Kian Chua et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response
Yasuhiro Asahina et al.
GASTROENTEROLOGY (2008)
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy
Ahmed El-Shamy et al.
HEPATOLOGY (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T. Asselah et al.
GUT (2008)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Viral defense, carcinogenesis and ISG15: Novel roles for an old ISG
Ian F. Pitha-Rowe et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Cholesterol manipulation by west nile virus perturbs the cellular immune response
Jason M. Mackenzie et al.
CELL HOST & MICROBE (2007)
Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus
Robert E. Lanford et al.
HEPATOLOGY (2007)
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
Norio Akuta et al.
JOURNAL OF HEPATOLOGY (2007)
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses
Deborah J. Lenschow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
Xiao-Song He et al.
HEPATOLOGY (2006)
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load
N Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
XD Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
VISA is an adapter protein required for virus-triggered IFN-β signaling
LG Xu et al.
MOLECULAR CELL (2005)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
KJ Helbig et al.
HEPATOLOGY (2005)
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
S Zeuzem et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees
CB Bigger et al.
JOURNAL OF VIROLOGY (2004)
Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example
KGM Moons et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Genome-scale functional profiling of the mammalian AP-1 signaling pathway
SK Chanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A Suzuki et al.
NATURE GENETICS (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Genomic analysis of the host response to hepatitis C virus infection
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
CB Bigger et al.
JOURNAL OF VIROLOGY (2001)
A high-throughput SNP typing system for genome-wide association studies
Y Ohnishi et al.
JOURNAL OF HUMAN GENETICS (2001)
Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients
LE Adinolfi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
